Pharmaceutical Business Review
Anonymous User | Login

ProtNeteomix - Developing Applications for Drug Discovery & Development and Diagnostics

Company Product List White Papers

Press Releases

Case Studies

ProtNeteomix is a biotechnological company specialised in developing cost-effective microarray-based applications for Drug Discovery & Development and Diagnostics.

The main challenge facing the biopharmaceutical industry is the extremely high overall cost and time consuming nature of discovery and development processes. ProtNeteomix provides faster and cheaper solutions based on innovative miniaturised arrays for obtaining valuable information about target proteins and generating effective drugs to combat human diseases.

The company's microarrays can be integrated into different steps of DDD programs including high-throughput screening, lead optimisation and validation, selecting the most appropriate candidates for pre-clinical assays. They might also be used to evaluate the safety and efficacy of leads in clinical trials. Our microarray methodology makes it possible to speed up drug design, replace expensive in vivo tests by in vitro assays, cut the huge expenditure wasted on evaluating "useless" leads, as well as demonstrating the strengths of the best drug candidates.

ProtNeteomix proposes its small molecule microarray service to screen compound libraries against desired target proteins. The straightforward method developed uses non-covalent immobilisation of compounds on a support that allows rapid and sensitive screening of different type of molecules in a single assay.

ProtNeteomix also manufactures customised protein microarrays (proteins, antibodies and peptides) and provides corresponding services for basic and applied biomedical research.

Core Miniaturised Technologies:

• Cell-free protein synthesis and in vitro assembled protein arrays
• Total protein and compartment-specific protein arrays
• Chemically synthesised and phage-displayed peptide arrays
• Antibody arrays (mono and dual fluorescence detection of target proteins)
• Small molecule arrays

ProtNeteomix's Microarray Applications:

• Molecular interactions: protein-protein, protein-nucleic acid, protein-ligand…
• Proteome post-translational modifications (phosphorylation, acetylation…)
• Signalling pathways
• Biomarker discovery
• Target discovery and validation
• Immune response
• Epitope mapping
• Guiding vaccines
• Immunoassays
• Compound library screening
• Lead optimisation

Sectors of activity:

• Drug Discovery & Development   
• Diagnostics   
• Proteomics
• System biology

To find out more, please see our brochure or visit our website.

Contact:
ProtNeteomix SAS
2, rue de la Houssinière
44322 Nantes
France

Tel: +33 2 51 12 56 26 or +33 2 51 12 56 20

Fax: +33 2 51 12 56 26
contact@protneteomix.com

www.protneteomix.com


Request more information